Clinical Trial Update: A Clinical Trial of TG6050 in Patients With Metastatic Non-Small Cell Lung Cancer (Delivir) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating TG6050 for metastatic non-small cell lung cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• TG6050

Snippet

Sponsor: Transgene | Conditions: Non-small Cell Lung Cancer | Phase 1 | Status: TERMINATED